Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol for prevention of myocardial injury following angioplasty
IRCT201412088307N11Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of allopurinol in coronary arteriosclerosis, sponsored by Tabriz University of Medical Sciences. Started Oct 2014; status: completed.
02
Drugs
allopurinol
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT201412088307N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201412088307N11.